Trial Profile
Study of nivolumab in Japanese patients with malignant melanoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2018 New trial record